Molecular Basis of Anti-fibrosis via Destruction of an Organ Self-repair System
通过破坏器官自我修复系统抗纤维化的分子基础
基本信息
- 批准号:14207005
- 负责人:
- 金额:$ 28.87万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Myofibroblast formation and overproduction of extra-cellular matrix (ECM) are common events in the pathogenesis of tissue fibrosis under chronic injuries, such as liver cirrhosis, pulmonary fibrosis and cardiomyopathy. In the present study, we found that HGF directly targeted the interstitial myofibroblasts and reduced ECM accumulation using the animal model of pulmonary fibrosis, liver cirrhosis and dilated cardiomyopathy.1) Regression of pulmonary fibrosis by HGE :We used bleomycin-injected mice as a model of lung fibrosis and found that HGF elicited apoptotic changes in the myofibroblast cell population in vivo. Furthermore, we obtained in vitro evidence that : (i) HGF degraded ECM proteins (i.e., cell anchorage) around the myofibroblasts, via induction of proteinases such as MMP-9/-1/-2 ; (ii) under such ECM-deficient conditions, the myofibroblasts lose the anchorage then anoikis-like apoptotic cell death occurred. Importantly, an MMP-inhibitor diminished HGF-mediated apoptotic cell death of myofibroblasts, in vitro as well as in vivo, thus indicating that HGF-induced anti-fibrotic effects largely depended on inductions of MMPs by HGF. We published these results in FASEB-Journal 19 : 580 (2005)2) Reduction of interstitial fibrosis in liver cirrhosis and cardiomyopathy by HGF :In the rat model of liver cirrhosis, HGF enhanced myofibroblast apoptosis and inhibited proliferation of interstitial myofibroblasts. These effects were associated with the reduction of ECM-accumulated areas. In vitro, HGF counteracted the PDGF-mediated proliferation of the lipocyte-derived myofibroblasts. In the hamster model of cardiomyopathy, HGF reduced TGF-beta production in the interstitial myofibroblasts, followed by the reduction of ECM as well as improvement in the cardiac functions. These outcomes were published in Am-J-Pathol 166 : 1017 (2005) and in Am-J-Physiol 288 : H2131 (2005), respectively.
肌成纤维细胞的形成和细胞外基质(ECM)的过量产生是慢性损伤下组织纤维化发病机制中的常见事件,例如肝硬化、肺纤维化和心肌病。在本研究中,我们通过肺纤维化、肝硬化和扩张型心肌病的动物模型发现HGF直接靶向间质肌成纤维细胞并减少ECM积累。1) HGE对肺纤维化的消退:我们使用注射博来霉素的小鼠作为模型肺纤维化的研究发现,HGF 引起体内肌成纤维细胞群的凋亡变化。此外,我们获得的体外证据表明:(i) HGF 通过诱导 MMP-9/-1/-2 等蛋白酶,降解肌成纤维细胞周围的 ECM 蛋白(即细胞锚定); (ii)在这种ECM缺陷的条件下,肌成纤维细胞失去锚定,然后发生失巢凋亡样细胞凋亡。重要的是,MMP 抑制剂在体外和体内均可减少 HGF 介导的肌成纤维细胞凋亡细胞死亡,因此表明 HGF 诱导的抗纤维化作用很大程度上取决于 HGF 对 MMP 的诱导。我们将这些结果发表在 FASEB-Journal 19 : 580 (2005)2) HGF 减少肝硬化和心肌病中的间质纤维化:在肝硬化大鼠模型中,HGF 增强肌成纤维细胞凋亡并抑制间质肌成纤维细胞增殖。这些影响与 ECM 累积面积的减少有关。在体外,HGF 抵消了 PDGF 介导的脂肪细胞来源的肌成纤维细胞的增殖。在仓鼠心肌病模型中,HGF 减少间质肌成纤维细胞中 TGF-β 的产生,随后减少 ECM 并改善心脏功能。这些结果分别发表在 Am-J-Pathol 166 : 1017 (2005) 和 Am-J-Physiol 288 : H2131 (2005) 中。
项目成果
期刊论文数量(395)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Adenoviral gene transduction of hepatocyte growth factor elicits inhibitory effects for hepatoma.
肝细胞生长因子的腺病毒基因转导可引起肝癌的抑制作用。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Okunishi;K. et al.;Shigemura N. et al.;Fujiwara H. et al.;Futamatsu H. et al.;Murakami M. et al.;Shigemura N. et al.;Ito W.et al.;Isogawa K. et al.;Kashiwakura Y. et al.;Imai Y.et al.;Ishihara N. et al.;Chiyonobu T. et al.;Yuge K.et al.
- 通讯作者:Yuge K.et al.
L.W.Qian, et al.: "Co-cultivation of pancreatic cancer cells with orthotopic tumor-derived fibroblasts : fibroblasts stimulate tumor cell invasion via HGF secretion whereas cancer cells exert a minor regulative effect on fibroblasts HGF production"Cancer
L.W.Qian 等人:“胰腺癌细胞与原位肿瘤来源的成纤维细胞的共培养:成纤维细胞通过 HGF 分泌刺激肿瘤细胞侵袭,而癌细胞对成纤维细胞 HGF 的产生发挥较小的调节作用”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
水野信哉, 他: "臨床免疫2003"科学論評社. 9 (2003)
Shinya Mizuno 等人:“临床免疫学 2003”科学评论出版 9 (2003)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
H.Funakoshi, et al.: "Identification of Gas 6, a putative ligand for Sky and Axl receptor tyrosine kinases, as a novel neurotrophic factor for hippocampal neurons"J.Neursci.Res.. 68. 150-160 (2002)
H.Funakoshi 等人:“Gas 6 的鉴定,Sky 和 Axl 受体酪氨酸激酶的推定配体,作为海马神经元的新型神经营养因子”J.Neursci.Res.. 68. 150-160 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAMURA Toshikazu其他文献
NAKAMURA Toshikazu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAMURA Toshikazu', 18)}}的其他基金
DISTANCE MEASUREMENTS OF FIBROUS PRION PROTEINS BY PULSE ESR SPECTROSCOPY
通过脉冲 ESR 光谱法测量纤维状朊病毒蛋白的距离
- 批准号:
24654112 - 财政年份:2012
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Analysis of molecular mechanisms that reciprocally regulate growth and differentiation of mature hepatocytes
成熟肝细胞生长和分化相互调节的分子机制分析
- 批准号:
21390079 - 财政年份:2009
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Investigation of Spin Dynamics and Development of Devices for Low-Dimensional Electronic Phases
自旋动力学研究和低维电子相器件的开发
- 批准号:
20340095 - 财政年份:2008
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Mechanisms of Tissue Regeneration through the Conversion of HGF Receptor Signaling in Response of Injury
通过损伤反应中 HGF 受体信号转导实现组织再生的分子机制
- 批准号:
18390087 - 财政年份:2006
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Investigation of the electronic states in the successive SDW transitions of one-dimensional organic conductors
一维有机导体连续 SDW 跃迁中电子态的研究
- 批准号:
13640375 - 财政年份:2001
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Studies on Tissue Morphogenesis, Organogenesis and Repair by HGF
HGF 的组织形态发生、器官发生和修复研究
- 批准号:
11308025 - 财政年份:1999
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular and cellular biological analyzes of morphogenesis modulated by HGF
HGF 调节形态发生的分子和细胞生物学分析
- 批准号:
08408027 - 财政年份:1996
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Inhibitory effects of HGF antagonist on invasion/metastasis of tumor cells.
HGF拮抗剂对肿瘤细胞侵袭/转移的抑制作用。
- 批准号:
07557199 - 财政年份:1995
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Molecular mechanisms of organ regeneration and homeoslasis by injurin/HGF system.
Injurin/HGF 系统器官再生和稳态的分子机制。
- 批准号:
05404080 - 财政年份:1993
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for General Scientific Research (A)
Development of Large Scale Expression, Preparation, and Highly Sensitive Immunoassay Methods for Hepatocyte Growth Factor
肝细胞生长因子大规模表达、制备和高灵敏免疫分析方法的开发
- 批准号:
03558020 - 财政年份:1991
- 资助金额:
$ 28.87万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似海外基金
Development of Novel Small Molecule Anti-Fibrotic Agent for the Treatment of Systemic Scleroderma
治疗系统性硬皮病的新型小分子抗纤维化药物的开发
- 批准号:
10609109 - 财政年份:2023
- 资助金额:
$ 28.87万 - 项目类别:
Myeloid sphingolipid regulation of tissue resolution and regeneration responses
骨髓鞘脂对组织分辨率和再生反应的调节
- 批准号:
10562518 - 财政年份:2022
- 资助金额:
$ 28.87万 - 项目类别:
Repurposing esomeprazole for the treatment of scleroderma
重新利用埃索美拉唑治疗硬皮病
- 批准号:
10535112 - 财政年份:2022
- 资助金额:
$ 28.87万 - 项目类别: